Mimedx (MDXG) Net Income Growth (1y) (2012 - 2024)
Mimedx (MDXG) Net Income Growth (1y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 63.48% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Mimedx | 635.35 Mn | 475.58 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 170.45% |
| Jun 30, 2024 | 100.05% |
| Mar 31, 2024 | 106.58% |
| Dec 31, 2023 | -77.73% |
| Sep 30, 2023 | 96.34% |
| Jun 30, 2023 | 25.92% |
| Mar 31, 2023 | 71.01% |
| Dec 31, 2022 | 4,839.70% |
| Sep 30, 2022 | -260.24% |
| Jun 30, 2022 | -510.91% |
| Mar 31, 2022 | -25.14% |
| Dec 31, 2021 | 101.20% |
| Sep 30, 2021 | 87.95% |
| Jun 30, 2021 | 78.99% |
| Mar 31, 2021 | -73.86% |
| Dec 31, 2020 | -121.78% |
| Sep 30, 2020 | -256.85% |
| Jun 30, 2020 | 50.81% |
| Mar 31, 2020 | 63.68% |
| Dec 31, 2019 | 79.36% |